Table 1.

Demographics, Follow-Up Time and 10-Year Fracture Risks

	White (12,758)	Black (7,844)	Hispanic (3,587)
Age	64.5 ± 9.9	61.2 ± 9.3	60.2 ± 8.7
Male	53.1%	35.1%	44.9%
BMI	30.3 ± 6.4	32.3 ± 7.6	30.9 ± 6.4
Average visits per year	4.8 ± 4.1	7.2 ± 6.2	7.0 ± 5.2
Average years of follow-up	3.7 ± 1.8*	3.9 ± 1.8	3.7 ± 1.8*
Prior fracture (any)	5.0% *	4.0%	4.9%*
Chronic obstructive pulmonary disease	9.2%	10.3%	6.3%
Steroids, 3 months of use	0.5%*	0.9%	0.5%*
Rheumatoid arthritis	1.3%*	1.6%*	1.6%*
Secondary osteoporosis	18.6%	22.1%	20.2%
Charlson Comorbidity Score	0.6 ± 1.0	1.1 ± 1.6	0.9 ± 1.4
10-year QFracture Risk of MOF	4.7% ± 5.4%	2.2 % ± 2.5%	2.4% ± 2.6%
10-year FRAX Risk of MOF	7.5% ± 5.0%	3.0% ± 2.1%	3.5% ± 2.2%
10-year QFracture Risk of Hip Fracture	2.3% ± 4.7%	0.6% ± 2.0%	0.9% ± 2.0%
10-year FRAX Risk of Hip Fracture	1.9% ± 3.0%	0.6% ± 1.0%*	0.6% ± 1.1%*

Values marked with astericks (*) do not significantly differ